MIT Faces Challenges, Says Corporation Chairman
When John Reed ’61, SM ’65, chairman of the MIT Corporation, reported on the Institute at a recent alumni gathering in Northern California, he noted the positives—and the challenges.
“We continue to get great students and we have great faculty, and we would have to say that the basic mission of the school is being fulfilled quite well,” he said. “The two problems we have are our buildings are getting old and the model of how American research universities function is broken.”
As chairman, Reed examines the hard realities of running a major enterprise with expectations of excellence. And as the former chairman of Citigroup and the New York Stock Exchange, he brings a sharp business perspective to his role. Clearly, if MIT were a business, it would be losing money on its primary products—education and research. Tuition covers only about 28 percent of educational costs, and outside funding for research conducted on campus covers some 80 percent of costs.
“Obviously we are not going to make money on tuition or research,” Reed said. “The question is, can we earn enough money on the endowment or raise enough money to keep the institution on the path we want to be on?”
MITx, the Institute’s new online-learning experiment, is a response to another major challenge—the Internet. What MIT learns from MITx will improve the campus learning experience, he believes, because “it is going to force us to make residential learning even better than it is today.”
Hear Reed’s talk: alum.mit.edu/pages/sliceofmit/2012/02/29/corporation-chairman.
Keep Reading
Most Popular
The inside story of how ChatGPT was built from the people who made it
Exclusive conversations that take us behind the scenes of a cultural phenomenon.
How Rust went from a side project to the world’s most-loved programming language
For decades, coders wrote critical systems in C and C++. Now they turn to Rust.
Design thinking was supposed to fix the world. Where did it go wrong?
An approach that promised to democratize design may have done the opposite.
Sam Altman invested $180 million into a company trying to delay death
Can anti-aging breakthroughs add 10 healthy years to the human life span? The CEO of OpenAI is paying to find out.
Stay connected
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.